David Sterman

January 29, 2012
The Best Way to Invest in Biotech Stocks

Rather than staking your money on smaller, risky biotech stocks and hoping it will lead to major gains, I've found a much better way to invest in these high-reward stocks.
January 27, 2012
These Small Stocks Could Provide BIG Gains Very Soon

These small stocks surged by at least 100% in 2011. Which ones have the fundamentals to rise even more in 2012?
January 24, 2012
This Rare Commodity Looks Set to Go on a Major Run...

A long-expected rebound may finally be at hand. Here's my favorite way to profit...
January 20, 2012
I've Found 18 Stocks that Could Have BIG Upside -- and Limited Downside

This simple metric points the way to stocks with value AND growth.
January 18, 2012
3 Small-Cap Stocks with Heavy Insider Buying

These "off-the-radar" plays might deliver solid upside in 2012. Here's why...
January 17, 2012
Carl Icahn's Top Stock Idea Right Now

By doubling down, the super-investor should take home a nice payday with this stock. Here are the details...
January 14, 2012
Now's the Time to Buy Small Caps -- Especially These 2 Stocks

If history is any guide, then it's time to buy. Here are two of my top picks...
January 12, 2012
2 Upstart Stocks with 50% Upside

These two smaller companies are stealing market share from the big boys. Their moves could pay off big for investors...
January 11, 2012
This Retail Stock is in Deep Trouble

A newspaper report raises big concerns, making my prior bankruptcy prediction an increasingly likely outcome. Here's why...
January 8, 2012
Take a Look at My "Cheat Sheet" of Undervalued Stocks

This simple metric has revealed no less than 15 companies that are minting cash and have stocks trading at bargain-basement levels. Find out which is my favorite...

LEGAL DISCLAIMER: SmallStocks.com and its parent company, StreetAuthority, LLC, are publishers of financial news and opinions and NOT securities brokers/dealers or investment advisors. You are responsible for your own investment decisions. All information contained in our newsletters or on our web site(s) should be independently verified with the companies mentioned, and readers should always conduct their own research and due diligence and consider obtaining professional advice before making any investment decision. As a condition to accessing our materials and web sites, you agree to our Terms and Conditions of Use, available here, including without limitation all disclaimers of warranties and limitations on liability contained therein. Owners, employees and writers may hold positions in the securities that are discussed in our newsletters or on our web site.